"Hungary Pharmaceuticals & Healthcare Report Q4 2014" Now Available at Fast Market Research
C hallenges are in store for the pharmaceutical sector in 2015, as a harsh business environment and large regulatory burden weigh on market growth . Our country risk team also see s potential headwinds to spending growth, namely Hungary's excessive government deficits. Under Deficit Procedure rules, Hungary will be forced to trim back its fiscal spending, with negative implications for healthcare. Pricing pressures and slow uptake of new medicines will continue to present near-term headwinds to pharmaceutical sales, as will...
View full press release